Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cyclacel Pharmaceuticals Inc CYCC

Alternate Symbol(s):  CYCCP

Healthcare Biotechnology
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYCC)

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

GlobeNewswire 1 day ago

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

GlobeNewswire 7 days ago

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire 9 days ago

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer

GlobeNewswire April 1, 2024

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire March 19, 2024

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 13, 2024

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

GlobeNewswire March 7, 2024

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

GlobeNewswire March 6, 2024

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

GlobeNewswire February 20, 2024
View More News ››

Opinion & Analysis (NDAQ:CYCC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CYCC)

Cyclacel Pharmaceuticals to Release First Quarter 2024 Finan

News; $CYCCP Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsBERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE...
whytestocks - 1 day ago

CYCC.....FOMO's wanted....sign up to the Chasers list

JMHO
Iseneschal - April 25, 2024

CYCC.....zero volume at the low

No the bottom feeders are offing their paper
Iseneschal - April 25, 2024

CYCC....N.L.O.D $1.41

Yesterdays vol & price action was just a Pump & Dump by none other than the Infamous Mr. Maggot !!!!!
Iseneschal - April 25, 2024

CYCC....N.L.O.D.....$1.59

Ya have to be ready for these RS thinners throwing everyone a "curveball" Market Makers are throwing a few of these lately
Iseneschal - April 25, 2024

CYCC....I am totally rid of this

sec.gov/Archives/edgar/data/1130166/000110465924051334/tm249520d5_s1.htm
Iseneschal - April 25, 2024
View more Bullboard ››

AKITA Drilling Ltd

AKITA Drilling Ltd

AKITA Drilling Ltd. is a Canada-based intermediate land drilling contractor. The Company and its subsidiaries provide ...
View More »